NBS-C BioScience & Consulting
Private Company
Funding information not available
Overview
Founded in 2008 and based in Vienna, NBS-C BioScience & Consulting operates as a specialized service provider in the biologics and diagnostics sectors. Its core business leverages Surface Plasmon Resonance (SPR) technology to offer critical analytical services for drug development, including mechanistic studies, biosimilar profiling, and immunogenicity assessment. Additionally, the company has a product arm developing and manufacturing monoclonal antibodies, recombinant proteins, and assay components for the allergy diagnostics market, positioning it at the intersection of contract research and reagent supply.
Technology Platform
Expertise in Surface Plasmon Resonance (SPR) using Biacore™ systems for label-free, real-time analysis of binding kinetics, affinity, and specificity of biomolecular interactions.
Opportunities
Risk Factors
Competitive Landscape
NBS-C competes with other specialized biophysics CROs and the in-house capabilities of large pharma. In the broader CRO market, it faces competition from giants like Charles River, LabCorp, and IQVIA, though its niche SPR focus is a differentiator. In reagent supply, it competes with large players like Thermo Fisher, Hycor, and ImmunoCAP suppliers.